Langerhans cell histiocytosis
For patient information, click here Template:DiseaseDisorder infobox
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Synonyms and keywords: Histiocytosis X; histiocytosis X syndrome; Hand-Schüller-Christian disease; Letterer-Siwe disease; histiocytosis X; eosinophilic granulomatosis unspecified; Langerhans cell granulomatosis; Langerhans cell histiocytosis-Hashimoto-Pritzker type; Langerhans cell histiocytosis, disseminated (clinical); Langerhans cell histiocytosis, unifocal (clinical); Langerhans cell histiocytosis of the lung; non-lipid reticuloendotheliosis; eosinophilic granuoloma; pulmonary histiocytosis X; pulmonary Langerhans cell granulomatosis
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Langerhans cell histiocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History amd Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies